Welcome to a special episode of RealTalk MS coming to you from Day Three of ECTRIMS 2019 in Stockholm, Sweden. This final day at ECTRIMS has become my favorite day of the conference because it's the day that I get to sit down with Dr. Bruce Bebo, the Executive Vice President of Research at the National MS Society, and get his perspective on the highlights of the entire conference. We're talking about new Phase 3 clinical trial outcomes, research that shows that lifestyle choices can impact the course and severity of MS, the importance of beginning disease-modifying therapy within 5 years of being diagnosed with MS, and how artificial intelligence is ushering in the age of personalized medicine.   We have a lot to talk about. Welcome to ECTRIMS 2019!

___________

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating & Review 

ECTRIMS 2019 Scientific Programme

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS ECTRIMS Day 3 Hosted By: Jon StrumGuest:        Dr. Bruce Bebo

Tags: MS, MultipleSclerosis, MSsociety, ECTRIMS2019, EMDSerono, RealTalkMS